Pressmeddelanden

Eevia Health Plc receives a 146 KSEK / 13 KEUR sales order for a bilberry extract Eevia Health Plc, ("Eevia" or "The Company"), has received sales order from Taiwan of c. 13 KEUR for an organically certified bilberry extract.
Eevia Health Plc to present at "Stora Aktiedagarna" in Stockholm Eevia Health Plc ("Eevia" or "The Company") by the CEO Stein Ulve will present at the event "Stora Aktiedagarna" in Stockholm, which is arranged between March 13th and March 15th...
Eevia Health Plc receives a 226 KSEK / 20 KEUR sales order for a chaga extract Eevia Health Plc ("Eevia" or "The Company") has received a 20 KEUR sales order for Feno-Chaga®  Organic from a health-food customer in Finland.
Eevia Health Plc receives a 282 KSEK / 25 KEUR sales order for a Lingonberry extract product Eevia Health Plc ("Eevia" or "The Company") has received a 25 KEUR sales order for a Lingonberry extract from a Finnish beauty brand. The end customer is a leading Finnish manufa...
Eevia Health Plc receives a 132 KSEK / 12 KEUR sales order for a chaga extract Eevia Health Plc ("Eevia" or "The Company") has received a 12 KEUR sales order for Feno-Chaga® M from a health-food customer in Finland.
REG MAR
Eevia Health Plc Interim Report Q4 - 2022 Eevia Health Plc ("Eevia" or "The Company") is releasing its quarterly financial report for the fourth quarter of 2022.
Visa fler pressmeddelanden

Rapporter

Video

Finansiell kalender

Delårsrapport Q1 2023 DELÅRSRAPPORT
Årsstämma ÅRSSTÄMMA
Delårsrapport Q2 2023 DELÅRSRAPPORT
Delårsrapport Q3 2023 DELÅRSRAPPORT

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.

Webbplats
https://eeviahealth.com/investors/

Handelsinformation

Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658

IR-Kontakt

Stein Ulve IR-kontakt [email protected]